0001104659-15-004489.txt : 20150226 0001104659-15-004489.hdr.sgml : 20150226 20150126165418 ACCESSION NUMBER: 0001104659-15-004489 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Flex Pharma, Inc. CENTRAL INDEX KEY: 0001615219 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 465087339 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 800 BOYLSTON STREET STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 BUSINESS PHONE: 617-874-1821 MAIL ADDRESS: STREET 1: 800 BOYLSTON STREET STREET 2: 24TH FLOOR CITY: BOSTON STATE: MA ZIP: 02199 CORRESP 1 filename1.htm

 

January 26, 2015

 

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

Re:                             Flex Pharma, Inc. (the “Company”)

Registration Statement on Form S-1 (File No. 333-201276)

 

Ladies and Gentlemen:

 

As a representative of the several underwriters of the Company’s proposed public offering of up to 4,615,000 shares of common stock, we hereby join the Company’s request that the effective date of the above-referenced Registration Statement be accelerated so that the above-referenced Registration Statement will be declared effective at 4:30 p.m. (EST) on January 28, 2015, or as soon thereafter as is practicable.

 

Pursuant to Rule 460 of the General Rules and Regulations of the Securities and Exchange Commission under the Securities Act of 1933, as amended, we wish to advise you that we have effected the following distribution of the Company’s Preliminary Prospectus, dated January 20, 2015, through the date hereof:

 

Preliminary Prospectus dated January 20, 2015:

625 copies to prospective underwriters, institutional investors, dealers and others

 

The undersigned advise that they have complied and will continue to comply, and that they have been informed by the participating underwriters and dealers that they have complied with and will continue to comply, with the requirements of Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.

 

[Remainder of Page Intentionally Left Blank]

 


 

 

Very truly yours,

 

 

 

JEFFERIES LLC

 

PIPER JAFFRAY & CO.

 

 

 

As Representatives of the several Underwriters

 

 

 

JEFFERIES LLC

 

 

 

 

 

 

By:

/s/ Dustin Tyner

 

 

 

Name:

Dustin Tyner

 

 

Title:

Managing Director

 

 

 

 

 

PIPER JAFFRAY & CO.

 

 

 

 

 

 

 

 

By:

/s/ Christie L. Christina

 

 

 

Name:

Christie L. Christina

 

 

Title:

Managing Director

 

 

[Signature Page to Underwriter Acceleration Request]